Weekly Insider Report: Biotech and Medical Stocks

The BHI Weekly Insider Report is posted on BHI once a week, usually on Sunday or Monday. BHI does not take any responsibility for any financial loss or damage caused by or related to the following reports. BHI does not guarantee the accuracy of the reports. The following information should be used for entertainment purposes only.


This week's report:

BIOTECH
bought TorreyPines Ther (TPTX): Dec 26-27, $6.91-$7
bought Pharmacyclics (PCYC): Dec 29-Jan 3, $4.85-$4.95
bought Favrille (FVRL): Dec 27-29, $2.52-$2.63

sold Amylin (AMLN): Dec 29-Jan 3, $35.89-$36.29
sold Myriad Genetics (MYGN): Jan 3, $32
sold Seattle Genetics (SGEN): Jan 3, $5.22
sold CYTYC Corp (CYTC): Jan 3, $28.75
sold Acorda Ther (ACOR): Jan 3, $15.30-$15.99
sold Dynavax (DVAX): Jan 3, $9-$9.10



DRUGS
bought Novogen (NVGN): Dec 27-Jan 3, $10-$10.42

sold Conor Medsystems (CONR): Dec 26-29: $31.30-$31.42
sold Altus Pharma (ALTU): Jan 3, $18.88-$18.90
sold Barr Pharma (BRL): Jan 3, $50.33



Medical Supplies
bought Emerging Vision (ISEE): Dec 28, $0.17

sold Wright Medical (WMGI): Jan 3-4, $23.06-$23.24
sold Arrow Intl (ARRO): Jan 3-4, $35.48-$35.51
sold Iridex (IRIX): Dec 29, $9.03
sold Immucor (BLUD): Jan 3, $30.04
sold Char Ther (CTU): Jan 2, $2.40


__________

Previous BHI Weekly Insider Reports
__________